tiprankstipranks
Trending News
More News >
BioCardia Inc (BCDA)
NASDAQ:BCDA
US Market

BioCardia (BCDA) Stock Forecast & Price Target

Compare
332 Followers
See the Price Targets and Ratings of:

BCDA Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
BioCardia
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BCDA Stock 12 Month Forecast

There Are No Analyst Ratings for BCDA In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BCDA Financial Forecast

BCDA Earnings Forecast

Next quarter’s earnings estimate for BCDA is -$0.17 with a range of -$0.20 to -$0.14. The previous quarter’s EPS was -$0.24. BCDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year BCDA has Performed in-line its overall industry.
Next quarter’s earnings estimate for BCDA is -$0.17 with a range of -$0.20 to -$0.14. The previous quarter’s EPS was -$0.24. BCDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year BCDA has Performed in-line its overall industry.

BCDA Sales Forecast

Next quarter’s sales forecast for BCDA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. BCDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year BCDA has Performed in-line its overall industry.
Next quarter’s sales forecast for BCDA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. BCDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year BCDA has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on BCDA
H.C. Wainwright
H.C. Wainwright
$25
Buy
2055.17%
Upside
Reiterated
11/13/25
BioCardia's Strategic Advancements and Financial Stability Drive Buy Rating
Alliance Global Partners Analyst forecast on BCDA
Alliance Global Partners
Alliance Global Partners
$6
Buy
417.24%
Upside
Reiterated
11/13/25
Analysts Offer Insights on Healthcare Companies: BioCardia (NASDAQ: BCDA) and BridgeBio Oncology Therapeutics (NASDAQ: BBOT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on BCDA
H.C. Wainwright
H.C. Wainwright
$25
Buy
2055.17%
Upside
Reiterated
11/13/25
BioCardia's Strategic Advancements and Financial Stability Drive Buy Rating
Alliance Global Partners Analyst forecast on BCDA
Alliance Global Partners
Alliance Global Partners
$6
Buy
417.24%
Upside
Reiterated
11/13/25
Analysts Offer Insights on Healthcare Companies: BioCardia (NASDAQ: BCDA) and BridgeBio Oncology Therapeutics (NASDAQ: BBOT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioCardia

3 Months
xxx
Success Rate
3/6 ratings generated profit
50%
Average Return
+6.83%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.83% per trade.
1 Year
Joseph PantginisH.C. Wainwright
Success Rate
1/6 ratings generated profit
33%
Average Return
-24.47%
reiterated a buy rating 4 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -24.47% per trade.
2 Years
xxx
Success Rate
2/6 ratings generated profit
33%
Average Return
-27.70%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -27.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BCDA Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
1
3
2
2
0
Buy
0
0
0
0
0
Hold
34
42
33
24
23
Sell
3
4
1
1
2
Strong Sell
0
0
0
0
0
total
38
49
36
27
25
In the current month, BCDA has received 0 Buy Ratings, 23 Hold Ratings, and 2 Sell Ratings. BCDA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

BCDA Stock Forecast FAQ

What is BCDA’s average 12-month price target, according to analysts?
Currently, no data Available
What is BCDA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for BCDA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is BCDA a Buy, Sell or Hold?
      Currently, no data Available
      What is BioCardia Inc’s price target?
      Currently, no data Available
      What do analysts say about BioCardia Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of BCDA?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.